Atlas Trials

ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer

Clinical trial NCT07542717 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07542717
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent or Metastatic Cervical Cancer
Start date
2026-04-10
Primary completion
2028-03-31
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.